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Abstract— Single inventory policy has been applied to 
entire types of drugs in hospitals, despite several 
different drug and demand characteristics. Shortages 
regularly occur, which may affect patients’ lives, 
especially when vital drugs are being administered to 
them. However, hospitals cannot store a large amount 
of every drug because of limited space and budget. 
The objective of this study was to develop a hospital 
inventory management system to minimise the total 
inventory costs, while maintaining patient safety 
levels. The study is concerned only with the medicines 
that have a high consumption value and took place in 
a large public hospital in Thailand. The most suitable 
policies are proposed for each drug category with the 
best performance obtained. The historical demand is 
classified by drug characteristics, consumption value 
and clinical importance, as well as the demand 
characteristics. We applied it and compared it with 
the current inventory policy (Min/Max), and 
inventory policies from previous studies, in order to 
investigate the most suitable inventory policy for each 
drug category and demand characteristic. The study 
found that a single inventory management system 
cannot be effectively applied for all medicines. It is 
because there are also categories of medicines 
characterised by their value and clinical importance. 
This is called the ABC/VEN classification. The 
inventory management in hospitals should be fitted to 
drug categories and demand characteristics, which 
are quite unique in the healthcare supply chain and 
are different from those applied to general 
manufacturing. 
Keywords— Inventory management, Hospital, Drug, 
Clinical importance 
1. Introduction 
Healthcare expenditure is generally concentrated 
on the use of drugs because they are important 
products in curative care. Hospitals have been 
controlling the costs of drugs, which are stocked 
excessively, to maintain high service levels as a 
requirement; especially in developing countries [1, 
2]. Holding high drug stocks involves extra costs, 
such as those for replacing expired and deteriorated 
drugs. Consequently, hospitals can ineffectively 
control annual expenditure [3, 4] and lose 
opportunities to service patients. 
In this case study of a large government hospital in 
Thailand, one single inventory policy is applied to 
all drugs in the hospital, without the consideration 
of demand patterns.  
The disadvantage of using one policy for all drugs 
in a hospital is that inventory problems occur, such 
as drug shortages, which then directly affect patient 
service levels, especially when using vital drugs. 
One common-used policy is called the Min/Max 
policy. The logic flow of this policy begins when 
the drug orders from each ward of a hospital are 
placed with the central drug department every 
morning. The daily transactions of drug orders are 
collected, with the order quantity based on the 
experience of the pharmacists. The drug usage is 
collated every month, and is called the monthly 
sale (Msale). When the levels of drug inventory on 
hand is less than or equal to 70–80% of Msale, the 
pharmacists in the drug inventory departments will 
place a purchase request (PR) to the procurement 
department; the suppliers will receive a purchase 
order (PO) from the procurement department the 
next day and the order quantity is the number of 
drugs that raise the inventory on hand up to 100–
150% of Msale [5].  
Here, in this study, we developed a drug inventory 
policy suitable for each drug category, rather than 
applying a single Min/Max policy for all 
categories. We proposed a planning system, 
consisting of: when to order, how much to order 
and how to handle the various types of drugs. 
Establishing a suitable policy for each demand type 
is the way to manage drug inventories in a hospital. 
A suitable inventory policy should reduce the total 
inventory cost while still maintaining the service 
levels to patients.  
This study is concerned only with the medicines in 
the outpatient department (OPD) of a large public 
hospital in Thailand, retrieved from the records 
available on the Hospital Information System (HIS) 
for the period 2009-2012. Only high consumption 
value drugs (which are about 70% of total annual 
drug value) are taken into account.  
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Selected inventory models are tested for each drug 
category and demand characteristic. Then, a 
suitable inventory policy for each drug type was 
developed. 
2. Research Framework 
The research processes began with collecting data 
using interviews and surveys at the site. Then we 
classified the drugs using the ABC/VEN analysis. 
ABC relates to the consumption value and VEN 
relates to clinical importance. In this study, we 
focussed on drugs with a high consumption value 
(A class). The current policy and inventory policies 
from previous studies were compared, in order to 
find a suitable policy for each drug category. Then, 
a suitable inventory policy for each drug 
characteristic was proposed. These processes are 
summarised in Figure 1. 
 
Figure 1 Research Processes 
 
From the 1,951 drug SKUs (Stock keeping units) in 
the central drug store in fiscal year 2012, the A 
category, which account for 70% of the total 
expenditure, was selected for this study. By 
considering the VEN analysis, the A category of 
drugs can be divided into the following items: 
drugs with high consumption value and vital 
clinical importance (AV); drugs with high 
consumption value and essential clinical 
importance (AE); and drugs with high consumption 
value and non-essential clinical importance (AN). 
Then the historical demands of each drug category 
were analysed. The current Min/Max inventory 
policy in the hospital was compared to the 
inventory policies selected from the previous 
studies. 
 
3. Literature Review 
3.1 Inventory Management 
Inventory management is a trade-off between the 
costs of keeping an inventory versus the benefits of 
holding it. High inventory levels result in increased 
carrying costs but lower the possibility of lost sales 
because of stock-outs and slowing production, 
which can result from inadequate stocking [5, 7, 
10] 
Lead time (LT) is the time elapsed between 
ordering items and receiving them from suppliers. 
The reorder point (ROP) is the level that stock 
reaches when a new order must be placed [6, 8, 11] 
Safety stock or buffer stock is a quantity of a drug 
inventory held as a reserve to safeguard against 
variations in demand and LT for procurement. 
Safety stock is one factor to consider in 
establishing the ROP. Another factor to be 
considered, when replenishing drug supplies, is 
service levels, meaning the ratio between the 
number of available products for customers and the 
total product demand. The order quantity model, 
which is widely used, is the economic ordering 
quantity (EOQ), which is calculated from the 
holding cost and the ordering cost. It is the quantity 
of materials to be ordered and minimises the total 
costs of carrying inventories and ordering costs [9, 
12]. 
To manage inventory, the inventory classification 
must be taken into account. The reason for 
classifying inventory is to reduce the need to 
control a plentiful item in the inventory. If all items 
have equally strict control, time and costs are 
unnecessarily wasted. Classification can help to 
focus on highly-prioritised items [7, 8, 12]. 
3.2 Drug Category 
Pareto ABC analysis is a method used for 
supporting stock management, which has stock 
volumes in the hundreds or more. The objective of 
this method is to reduce complexity and increase 
the efficiency of stock management. All products in 
stock are classified by the total value of sold 
product [8, 10]. In this study, the annual 
consumption value of the drugs in an OPD, in the 
fiscal year 2012, was arranged from low to high 
values and then divided into three groups: A, B and 
C. 
Group A items represent high usage and account 
for 70% of usage value; the total quantity is 10% of 
line items. 
Group B items represent average usage and account 
for 20% of usage value; the total quantity is 20% of 
line items. 
Finally, group C items represent low usage and 
account for 10% of the value expended; the total 
quantity is 70% of line items [8, 10, 12, 14]. 
VEN (vital, essential, non-essential) classification 
is used to determine the drug’s clinical importance. 
Drug administration in hospitals is complex and 
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different from other general industries. The effects 
of drug shortages have an impact on human lives. 
Therefore, ABC classification is not adequate in 
supporting drug inventory management. 
It was mentioned that VEN is another useful tool 
for defining which items on the inventory list must 
be held in stock [14, 15]. In the VEN system, drug 
items are classified by pharmacists in a hospital 
once a year to prioritise procurement. It was stated 
that the VEN system also helps pharmacists to 
determine which items should be kept in stock and 
which can be ordered when needed. The basic 
criteria for classifying drugs by VEN analysis are 
shown below [5, 15, 17]. 
• Category V: vital drugs are the most important 
drugs and needed for clinical therapy; such as 
vaccines and serums. 
• Category E: essential drugs are moderately 
important drugs used to cure less severe diseases 
than V items. 
• Category N: non-essential drugs are the least 
important drugs and are seldom used in the 
treatment of illness. 
In previous studies, only the ABC classification is 
taken into account. The level of clinical important 
was neglected. When we consider the VEN 
dimension in the ABC classes, nine categories from 
ABC/VEN matrix can be listed. These are AV, AE, 
AN, BV, BE, BN, CV, CE and CN which are 
shown in Table1. 
Table 1. ABC/VEN matrix 
  ABC category 











Vital (V) AV BV CV 
Essential 




AN BN CN 
*Only AV, AE and AN are considered in this study. 
3.3 Demand Characters and Inventory 
Policy 
To manage inventory, first of all we need to define 
the demand patterns [7, 8, 12, 17]. Most of the 
studies worked with the assumption that the 
distribution of drug demand and LT are normal [11, 
17]. However, some drug demands are non-normal 
distributions, which can be tested by Kolmogorov-
Smirnov [6]. Some drug demands have trends [10, 
17], the type of trend is tested by a run test and 
regression analysis considering the R-square (R2) 
[6]. Some drug demands are lumpy but some are 
static [7, 9, 12]. The Peterson–Silver rule is used to 
determine the variability of data by value (V) [18]. 
If V is less than 0.25, the demand is static. 
Otherwise, the demand is lumpy. 
The demand characters in the previous studies can 
be summarised as 1) Normal distribution with no 
trend but static demand; 2) Normal distribution 
with no trend but lumpy demand; 3) Normal 
distribution with trend demand; and 4) Non-normal 
distribution demand. 
(s,S) policy is applied for normal distribution with 
no trend demand [5, 6, 11]. 
where  (1) 
 (2) 
by which s = reorder point (unit) 
  = mean of demands (unit) 
 L = lead time (day) 
 z  = the standardized random 
variable 
 n  = service days in a week (day) 
 σ  = standard variation 
 S = maximum level (unit) 
 M = storage day (day) 
 k = special demand that known 
before (unit) 
They also applied (s,Q) policy for normal 
distribution with static demand [5, 6, 11]. 
where s = day(+1) (3) 
Q =  (4) 
by which s = reorder point (unit) 
  = mean of demands (unit) 
 L = lead time (day) 
 Q = Order quantity (unit) 
 N = storage day (day) 
 S = maximum level (unit) 
 I = inventory level at reorder 
point (unit) 
 y = the unit of boxes (unit) 
 mo = minimum order quantity (unit) 
Moreover, (s,Q) policy is applied for normal 
distribution with lumpy demand [5, 6, 11]. 
where s =  (5) 
Q =  (6) 
by which s = reorder point (unit) 
 L = lead time (day) 
  = mean of demands (unit) 
 z  = the standardized random 
variable 
 n  = service days in a week (day) 
 σ  = standard variation 
 Q = Order quantity (unit) 
 N = storage day (day) 
 S = maximum level (unit) 
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 I = inventory level at reorder 
point (unit) 
 y = the unit of boxes (unit) 
 mo = minimum order quantity (unit) 
(s,Q) policy is applied based on EOQ to normal 
distribution with no trend but static demand [7, 11, 
13, 17]. 
where s   (7) 
 Q =   (8) 
by which s = reorder point (unit) 
  = mean of demands (unit) 
 L = lead time (day) 
 Q = Order quantity (unit) 
 A = Ordering cost per time (baht 
per time) 
 D = Annual drug demand (unit per 
year) 
 h = holding cost (baht) 
 (s,Q) is also applied based on simple linear 
regression for normal distribution with trend 
demand [5, 10, 12]. 
where    (9) 
  (10) 
by which s = reorder point 
 z  =the standardized random 
variable 
 L = lead time (day) 
 σ  = standard variation 
  = mean of demands (unit) 
 c  = date of ordering drug 
 d  = date of receiving drug 
 d-c = lead time 
 Q = Order quantity (unit) 
 k = special demand that known 
before (unit) 
 a  = date begin to storage drug 
b  = date finish to storage drug 
b-a = number of day to storage 
drug (M) 
On the other hand, dynamic lot sizing is applied to 
normal distribution with no trend but lumpy 
demand [10]. 
where s = order every month (Fixed ordering 
time) 
 Q = Average weekly demand * 4 
by which the reorder point (s) are fixed by hospital 
policy and order quantity (Q) is ordered for 
monthly demand based on the demand of previous 
month, which is calculated every month. 
This dynamic lot sizing is also applied for the non-
normal distribution demand [5, 10]. 
These are all summarised in Table 2. 
Table 2. Inventory policy from previous studies for 
particular demand characteristics 
Demand 











[5, 6, 11] 
(s,Q) policy for static demand 
and pack size ordering: 
s = day(+1) 
Q =  
[5, 6, 11] 
(s,Q) policy based on EOQ: 
s  
Q =  








(s,S) policy for normal 
distribution demand: 
 
 [5, 6, 11] (s,Q) policy for lumpy demand 
and pack size ordering: 
s =  
Q =  
dynamic lot sizing 
s = order every month (Fixed 
ordering time) 















Dynamic lot sizing: 
s = order every month (Fixed 
ordering time) 
Q = Average weekly demand * 4 
[5, 10] 
4. Case study and data collection 
4.1 Input Data 
From interviewing pharmacists in the pharmacy 
department and central drug inventory of a large 
public hospitals, located in Bangkok, Thailand, and 
the previous studies [6], it was found that only the 
drug ordering policy, called Min/Max, is applied to 
all drugs. This causes inventory problems – both 
shortages and overstocking of some drugs. 
Therefore, if drug inventories can be controlled at a 
suitable quantity with clinical importance concerns, 
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patients should receive their required drugs at the 
right times and hospitals can manage expenditure 
more effectively, while achieving patient safety 
levels.  
For this reason, the current inventory policy was 
investigated and tested with the other inventory 
policies in the previous section. The data concerns 
only the medicines from the OPD of a large public 
hospital in Thailand, retrieved from the records 
available on the hospital information system (HIS) 
for the 2009–2012. Only drugs with a high 
consumption value – about 70% of total annual 
drug value – are focused on, the purpose being to 
reduce expenditures and increase the effectiveness 
of drug utilisation. Medical devices and other 
consumables are not included. 
4.2 Drug Categories and Demand 
Characters 
Because this study focus on the drugs that demand 
large expenditure from the hospital, drug demand 
of the OPD for the fiscal year 2012 were classified 
by ABC/VEN analysis according to both value 
consumption and vital criteria. Starting with value 
consumption of 1,951 items, the first 70% (208 
items) were classified into the A category, the next 
20% (327 items) into the B category and the next 
10% (1,416 items) into the C category.  
Further, to focus on each area of clinical 
importance (VEN), the summary results of analysis 
of A category drugs can be divided into three 
subcategories: drugs with a high consumption value 
and vital clinical importance (AV); drugs with a 
high consumption value and essential clinical 
importance (AE); and drugs with a high 
consumption value and non-essential clinical 
importance (AN). 
The historical consumption data of A category 
drugs, (high consumption value) in the record 
available on the hospital information system (HIS) 
database, between January 2009 through to 
December 2012, was analysed by boxplot to 
remove outliers; a run test was used to determine 
the randomness or trend data; a Kolmogorov–
Smirnov test was used to establish normality; and 
the Peterson–Silver rule was used to test variability. 
The data were analysed using Microsoft Excel 
version 2010. The examples of historical drug 





Figure 2 . (Up) Example of historical drug 
consumption which has normal distribution with no 
trend but static demand; (Down) Example of 
historical drug consumption which has normal 
distribution with no trend but lumpy demand 
 
 
Figure 3 . (Up) Example of historical drug 
consumption which has normal distribution with 
trend demand; (Down) Example of historical drug 
consumption which has non-normal distribution 
demand 
Each drug’s data is analysed and mapped to the 
four groups of demand characters: 1) Normal 
distribution with no trend but static demand; 2) 
Normal distribution with no trend but lumpy 
demand; 3) Normal distribution with trend demand; 
and 4) Non-normal distribution demand. It is found 
that drugs in the AV category have the 
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characteristics of groups one, two and four. Drugs 
in the AE category have the characteristics of 
groups one, two, three and four. Drug in the AN 
category have the characteristics of groups one and 
four. These are summarised in Table 3. 








Drug demand characters 
Group 1 Group2 Group3 Group4 
Normal 
distribution 
















AV   N/A  
AE     
AN  N/A N/A  
 
By considering the potential inventory policies for 
each demand characteristic (stated in Table 2), the 
data of each group in each category was tested. 
This was also compared with the current Min/Max 
policy. These are summarised in Table 4-6. 
Table 4. Potential suitable inventories’ policies for 
each demand characteristic of the AV category 
Drug demand characters 
Group 1 
Normal distribution  
with no trend but static 
demand 
Group2 
Normal distribution  






Min/Max Min/Max Min/Max 
(s,S) policy for normal 
distribution demand 




(s,Q) policy for static 
demand and pack size 
ordering 
(s,Q) policy for lumpy 
demand and pack size 
ordering 
- 
(s,Q) policy based on 
EOQ 
dynamic lot sizing 
- 
 
Table 5. Potential suitable inventories’ policies for 
each demand characteristic of the AE category 





















Min/Max Min/Max Min/Max Min/Max 
(s,S) policy for 
normal distribution 
demand 










(s,Q) policy for 
static demand and 
pack size ordering 
(s,Q) policy for 
lumpy demand 
and pack size 
ordering 
- - 
(s,Q) policy based 
on EOQ 







Table 6. Potential suitable inventories policies for 
each demand characteristic of the AN category 
Drug demand characters 
Group 1 
Normal distribution  





(s,S) policy for normal distribution 
demand 
dynamic lot sizing 
(s,Q) policy for static demand and 
pack size ordering - 
(s,Q) policy based on EOQ - 
 
4.3 Drug Performance Measurement 
The study of inventory management in hospitals  
[4-6] shows that there are several key performance 
indexes (KPIs) to measure the performance in 
hospital inventories. Average inventory level, 
shortage days, number of shortages and length of 
shortage are seen to be frequently used as KPIs. 
Typically, average inventory level is of the highest 
concern and commonly converted to inventory 
cost. 
However, vital drugs (V category) are different 
from essential and non-essential products since 
they have a very high health impact and patients 
take them to save lives. The inventory performance 
cannot consider only the typical lowest inventory 
cost or stock level.  
Here we applied a pairwise ranking technique to 
identify the most important performance for the 
AV drugs. We asked the experts, who are 
specialists in the field of healthcare logistics, to 
compare the key performance indicator (KPI) 
priority. 
First of all, each box in the matrix represents the 
intersection of KPIs (Key Performance Indexes) of 
inventory performances in the previous studies. 
There are average inventory level, shortage days, 
number of shortages and length of shortage. Then, 
the expert ranks each pair by indicating the more 
important KPIs in the appropriate box. Repeat this 
process until the matrix is filled as shown in Table 
7. 
 
Table 7. Result of the pairwise ranking for high 
consumption and vital drug category (AV category) 
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Then we listed the number of each alternative 
appears in the matrix and ranked them as shown in 
Table 8.  












Count 3 2 1 0 
Rank 1st 2nd 3rd 4th 
According to the pairwise ranking results in Table 
8, the most important KPI factors for the drug 
category AV is the number of drug shortages. The 
suitable policy for the vital drugs must, thererfore, 
consider the minimum number of shortages; 
whereas, the typical inventory cost KPIs are 
applied to AE and AN drugs. 
5. Results and Analysis 
All drug items were tested with all potential drug 
inventory policies listed in Table 4-6. The most 
suitable policy for each demand characteristic for 
each drug category are summarised in Table 9. 
Table 9. Suitable inventory polices for each 



































































































* = Major group of each drug category 
In the AV category, the results show that for the 
group 1-normal distribution with no trend but static 
demand, the (s,S) for normal distribution demand 
has the number of shortages as 20,962.30, 
compared to the 123,134.83 number of shortages 
from the Min/Max policy. For the group 2-normal 
distribution with no trend but lumpy demand, the 
(s,Q) for pack size ordering has 40.00 number of 
shortages whereas the Min/Max policy gives 
1,763.49 number of shortages. For the group 4-non-
normal distribution demand, the dynamic lot sizing 
has the number of shortages as 246.00, compared to 
177,790.61 number of shortages from the Min/Max 
policy. The results are shown in Figure 4. 
 
Figure 4. Number of shortages comparison 
between current inventory policy (Min/Max) and 
suggested inventory policies of drugs with high 
consumption value and deemed vital (AV category) 
In the AE category, the results show that for the 
group 1-normal distribution with no trend but static 
demand, the Min/Max policy has a total inventory 
cost of THB 98,049,370.75, and so the Min/Max 
policy is the suggested inventory policy for this 
group. For the group 2-normal distribution with no 
trend but lumpy demand, the dynamic lot sizing has 
a total inventory cost of THB 26,678,874.58, 
whereas the Min/Max policy was THB 
33,272,354.97.  
For the group 3-normal distribution with trend 
demand, the (s,Q), based on simple linear 
regression, has a total inventory cost of THB 
15,216,776.62, compared to THB 17,387,206.01 
for the Min/Max policy. For the group 4-non-
normal distribution demand, the dynamic lot sizing 
has a total inventory cost of THB 62,094,506.22, 
compared to THB 88,395,480.01 from the 
Min/Max policy. The results are shown in Figure 5. 
 
 





Figure 5. Cost comparison between current 
inventory policy (Min/Max) and suggested 
inventory policies of drugs with a high 
consumption value and deemed essential (AE 
category) 
In the AN category, the results show that for the 
group 1-normal distribution with no trend but static 
demand, the Min/Max policy has a total inventory 
cost of THB 1,128,432.29. For the group 4-non-
normal distribution demand, Min/Max policy has a 
total inventory cost of THB 1,400,546.50. 
Min/Max policy is the suggested inventory policy 
for all drugs in this group. The results are shown in 
Figure 6. 
 
Figure 6. Cost comparison between current 
inventory policy (Min/Max) and suggested 
inventory policies of drugs with a high 
consumption value and deemed non-essential (AN 
category) 
The results show that the suggested inventory 
policy can reduce the number of shortage in the AV 
category and reduce the total inventory cost for the 
AE and AN categories. In brief, the suggested 
inventory policies can reduce the number of 
shortages by as much as 92.98% and the total 
inventory cost by as much as 14.63%. 
6. Discussion 
The study show that using only ABC classification 
was not sufficient for drug inventory management, 
the clinical importance, which refers to VEN 
classification, must be taken into account. Nine 
metrics are proposed. The AV, AE and AN were 
selected in this study. 
Further, it found 3 drug characteristics in the AV 
drug category. These are normal distribution with 
no trend but static demand; normal distribution 
with no trend but lumpy demand; and non-normal 
distribution demand. The best policy fits are: the 
(s,S) for normal distribution demand for drugs with 
normal distribution with no trend but static 
demand; the (s,Q) for pack size ordering for drugs 
with normal distribution with no trend but lumpy 
demand; and the dynamic lot sizing for drugs with 
non-normal distribution demand. 
For the AE drug category, there are 4 drug 
characteristics. These are normal distribution with 
no trend but static demand; normal distribution 
with no trend but lumpy demand; normal 
distribution with trend demand; and non-normal 
distribution demand. It can be seen that Min/Max 
fits drugs with normal distribution with no trend 
but static demand; whereas, dynamic lot sizing fits 
drugs with both normal distribution with no trend 
but lumpy demand and non-normal distribution 
demand. The (s,Q) based on simple linear 
regression fits drugs with normal distribution with 
trend demand. 
For the AN drug category, there are 2 drug 
characteristics. These are normal distribution with 
no trend but static demand; and non-normal 
distribution demand. It can be seen that Min/Max 
fits both characteristics in this category. 
Noticeably, most of the drugs with a high 
consumption value and vital clinical importance 
(AV drug category) are not steadily consumed; 
they are only used for severe cases. These drugs 
should be at minimal shortages as they are critical 
for life saving; their availability must be ensured 
even though the holding costs are high. Inventory 
ordering should be conducted at fixed intervals. 
Safety stock and ROP are calculated based on mean 
and variance from the normal distribution in order 
to ensure particular levels of stock.  
Conversely, the drugs with high consumption value 
and essential clinical importance (AE drug 
category) are quite common and are prescribed 
steadily all through the year. Min/Max is the 
suitable inventory policy for most drugs in this 
category, which can minimise average inventory 
levels. Interestingly, for those drugs with the 
characteristics of normal distribution with trend, 
the inventory policy should be based on a simple 
regression model. The order quantity is calculated 
from the average demand plus the trend. 
Most drugs with high consumption value and non-
clinical importance (AN drug category) fit very 
well with the Min/Max inventory policy in order to 
minimise average inventory levels. 
 
7. Conclusion 
The study can be concluded that only single 
inventory policy cannot be applied to entire types 
of drugs in hospitals. The inventory management 
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policy should take into account both drug’s value 
and clinical importance factors. Also, demand 
characteristics under each drug category must be 
concerned. By applying suggested inventory policy 
in this study, it is found that the number of 
shortages can be reduced as much as 92.98% and 
the total inventory cost can be reduced 14.63%. 
Importantly, it must be noted that the drug 
inventory policy should be revised every year. This 
is due to the VEN classification being revised by 
hospital committees annually. Also, the ABC 
classes, which are revised every year according to 
annual demand and consumption, should also be 
taken into account. 
Briefly, drugs are different from ordinary products 
on the market. They have levels of clinical impact. 
A Min/Max inventory policy is not appropriate to 
manage all drugs in the hospital, as at present, 
because drugs in the hospital have several demand 
characteristics, and the inventory policy should be 
customized to match specific drug demand 
characteristics. 
For further research, it can be noted that the entire 
order policy presented in this paper can be 
considered as passive policy. The ordering is 
triggered by the ROP or a fixed period of time. On 
the other hand, if real-time demand and the stock 
levels can be shared with the hospital’s supplier, 
active replenishment can be accurately undertaken. 
This is called a vendor managed inventory (VMI). 
Its application and implementation in hospitals is 
promising, yet challenging. 
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